Literature DB >> 12552054

Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm.

R D Henderson1, T Rajah, A J Nicol, S J Read.   

Abstract

Posterior leukoencephalopathy syndromes have been reported with hypertension, and immunosuppressive and chemotherapy agents. Cerebral vasospasm on MR angiography (MRA) has been noted in cases due to eclampsia. The authors report a case of Balint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal methotrexate and cytarabine. Hypertension was not present. Diffuse, reversible arterial irregularities consistent with vasospasm were present on MRA during the acute illness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552054     DOI: 10.1212/01.wnl.0000042095.49520.1e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

Review 1.  Bronchogenic adenocarcinoma presenting as a synchronous solitary lytic skull lesion with ischaemic stroke--case report and literature review.

Authors:  David O'Connell; Chandrasekaran Kaliaperumal; Gerald Wyse; Julie McCarthy; Aisling Ryan
Journal:  BMJ Case Rep       Date:  2011-12-20

2.  Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment.

Authors:  Sofia Calado; Miguel Viana-Baptista
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

3.  [Acute bilateral loss of vision in posterior reversible encephalopathy syndrome].

Authors:  K S Bonsel; I Oberacher-Velten; K Hufendiek; H Jägle
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

4.  Postpartum angiopathy and other cerebral vasoconstriction syndromes.

Authors:  Aneesh B Singhal; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 5.  [The clinical syndrome of posterior cortical atrophy].

Authors:  E Karner; C Jenner; E Donnemiller; M Delazer; T Benke
Journal:  Nervenarzt       Date:  2006-02       Impact factor: 1.214

6.  Reversible posterior leucoencephalopathy syndrome: a cause of temporary cortical blindness.

Authors:  N Niyadurupola; C A M Burnett; L E Allen
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

7.  Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity.

Authors:  M E Haykin; M Gorman; J van Hoff; R K Fulbright; J M Baehring
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

8.  Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study.

Authors:  Carlos Kamiya-Matsuoka; Asif M Paker; Linda Chi; Ayda Youssef; Sudhakar Tummala; Monica E Loghin
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

9.  Primary brain tumors and posterior reversible encephalopathy syndrome.

Authors:  Carlos Kamiya-Matsuoka; David Cachia; Adriana Olar; Terri S Armstrong; Mark R Gilbert
Journal:  Neurooncol Pract       Date:  2014-09-14

10.  Reversible encephalopathy syndrome: report of 12 cases with follow-up.

Authors:  S Greco Crasto; L Rizzo; P Sardo; O Davini; R De Lucchi
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.